In-flow photooxygenation of aminothienopyridinones generates novel PTP4A3 phosphatase inhibitors
John S. Lazo, Charlottesville, VA (US); Elizabeth Sharlow, Butler, PA (US); Peter Wipf, Pittsburgh, PA (US); Nikhil Tasker, Trumbull, CT (US); and Ettore Rastelli, Pittsburgh, PA (US)
Assigned to University of Virginia Patent Foundation, Charlottesville, VA (US); and University of Pittsburgh—Of the Commonwealth System of Higher Education, Pittsburgh, PA (US)
Appl. No. 17/309,259
Filed by University of Virginia Patent Foundation, Charlottesville, VA (US); and University of Pittsburgh—Of the Commonwealth System of Higher Education, Pittsburgh, PA (US)
PCT Filed Nov. 12, 2019, PCT No. PCT/US2019/061003 § 371(c)(1), (2) Date May 12, 2021, PCT Pub. No. WO2020/102243, PCT Pub. Date May 22, 2020.
Claims priority of provisional application 62/870,252, filed on Jul. 3, 2019.
Claims priority of provisional application 62/758,759, filed on Nov. 12, 2018.
Claims priority of provisional application 62/758,861, filed on Nov. 12, 2018.
Prior Publication US 2022/0017534 A1, Jan. 20, 2022
Int. Cl. C07D 495/04 (2006.01)
CPC C07D 495/04 (2013.01)
8 Claims
1. A compound, or a pharmaceutically acceptable salt thereof, selected from one of the following compounds
